{"id":27875,"date":"2026-06-17T16:53:44","date_gmt":"2026-06-17T20:53:44","guid":{"rendered":"https:\/\/www.cryoport.com\/?p=27875"},"modified":"2026-06-17T17:00:30","modified_gmt":"2026-06-17T21:00:30","slug":"cryoport-systems-a-labiotech-sur-les-points-de-rupture-des-chaines-dapprovisionnement-de-la-cgt-2","status":"publish","type":"post","link":"https:\/\/www.cryoport.com\/fr\/cryoport-systems-a-labiotech-sur-les-points-de-rupture-des-chaines-dapprovisionnement-de-la-cgt-2\/","title":{"rendered":"Une nouvelle r\u00e9flexion de l’ISCT examine pourquoi la croissance des CGT n\u00e9cessite un mod\u00e8le op\u00e9rationnel diff\u00e9rent"},"content":{"rendered":"","protected":false},"excerpt":{"rendered":"

La mani\u00e8re dont le secteur appr\u00e9hende la question de l\u2019\u00e9chelle commence \u00e0 \u00e9voluer. Pendant des d\u00e9cennies, la croissance du d\u00e9veloppement biopharmaceutique a suivi un sch\u00e9ma bien connu. \u00c0 mesure que les programmes avancent, la production s\u2019\u00e9tend et le d\u00e9bit augmente, ce qui permet aux traitements de passer d\u2019un cadre d\u2019essais cliniques limit\u00e9s en phase pr\u00e9coce \u00e0 des populations de patients plus larges. Un nouvel article de Cryoport Systems, publi\u00e9 par l\u2019Interna\u0446\u0438\u043e\u043d\u0430l Society for Cell & Gene Therapy (ISCT), examine comment la notion d\u2019\u00e9chelle se comporte diff\u00e9remment dans le domaine des th\u00e9rapies avanc\u00e9es et pourquoi le secteur pourrait devoir repenser les mod\u00e8les op\u00e9rationnels utilis\u00e9s pour les soutenir. <\/p>\n","protected":false},"author":38,"featured_media":27881,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"single-with-related.php","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[226],"tags":[601,594,517],"class_list":["post-27875","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-articles-fr","tag-gestion-de-la-chaine-dapprovisionnement-mondiale","tag-therapie-cellulaire","tag-therapie-genique"],"acf":[],"yoast_head":"\nUne nouvelle r\u00e9flexion de l'ISCT examine pourquoi la croissance des CGT n\u00e9cessite un mod\u00e8le op\u00e9rationnel diff\u00e9rent - Cryoport Systems<\/title>\n<meta name=\"description\" content=\"La mani\u00e8re dont le secteur appr\u00e9hende la question de l\u2019\u00e9chelle commence \u00e0 \u00e9voluer. Depuis des d\u00e9cennies, la croissance du d\u00e9veloppement biopharmaceutique suit un sch\u00e9ma bien connu. \u00c0 mesure que les programmes avancent, la production s\u2019intensifie et le d\u00e9bit augmente, ce qui permet aux traitements de passer d\u2019un cadre d\u2019essais cliniques limit\u00e9s en phase pr\u00e9coce \u00e0 des populations de patients plus larges. Un nouvel article de Cryoport Systems, publi\u00e9 par l\u2019Interna\u0446\u0438\u043e\u043d\u0430l Society for Cell & Gene Therapy (ISCT), examine comment la notion d\u2019\u00e9chelle se comporte diff\u00e9remment dans le domaine des th\u00e9rapies avanc\u00e9es et pourquoi le secteur pourrait devoir repenser les mod\u00e8les op\u00e9rationnels utilis\u00e9s pour les soutenir.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cryoport.com\/fr\/cryoport-systems-a-labiotech-sur-les-points-de-rupture-des-chaines-dapprovisionnement-de-la-cgt-2\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Une nouvelle r\u00e9flexion de l'ISCT examine pourquoi la croissance des CGT n\u00e9cessite un mod\u00e8le op\u00e9rationnel diff\u00e9rent - Cryoport Systems\" \/>\n<meta property=\"og:description\" content=\"La mani\u00e8re dont le secteur appr\u00e9hende la question de l\u2019\u00e9chelle commence \u00e0 \u00e9voluer. Depuis des d\u00e9cennies, la croissance du d\u00e9veloppement biopharmaceutique suit un sch\u00e9ma bien connu. \u00c0 mesure que les programmes avancent, la production s\u2019intensifie et le d\u00e9bit augmente, ce qui permet aux traitements de passer d\u2019un cadre d\u2019essais cliniques limit\u00e9s en phase pr\u00e9coce \u00e0 des populations de patients plus larges. Un nouvel article de Cryoport Systems, publi\u00e9 par l\u2019Interna\u0446\u0438\u043e\u043d\u0430l Society for Cell & Gene Therapy (ISCT), examine comment la notion d\u2019\u00e9chelle se comporte diff\u00e9remment dans le domaine des th\u00e9rapies avanc\u00e9es et pourquoi le secteur pourrait devoir repenser les mod\u00e8les op\u00e9rationnels utilis\u00e9s pour les soutenir.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cryoport.com\/fr\/cryoport-systems-a-labiotech-sur-les-points-de-rupture-des-chaines-dapprovisionnement-de-la-cgt-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Cryoport Systems\" \/>\n<meta property=\"article:published_time\" content=\"2026-06-17T20:53:44+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-06-17T21:00:30+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cryoport.com\/wp-content\/uploads\/2026\/06\/ISCT-News-Article.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"628\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"smendez\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@cryoport\" \/>\n<meta name=\"twitter:site\" content=\"@cryoport\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"smendez\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/cryoport-systems-a-labiotech-sur-les-points-de-rupture-des-chaines-dapprovisionnement-de-la-cgt-2\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/cryoport-systems-a-labiotech-sur-les-points-de-rupture-des-chaines-dapprovisionnement-de-la-cgt-2\\\/\"},\"author\":{\"name\":\"smendez\",\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/#\\\/schema\\\/person\\\/41e3344a83f354e30051a36b4e0a5f86\"},\"headline\":\"Une nouvelle r\u00e9flexion de l’ISCT examine pourquoi la croissance des CGT n\u00e9cessite un mod\u00e8le op\u00e9rationnel diff\u00e9rent\",\"datePublished\":\"2026-06-17T20:53:44+00:00\",\"dateModified\":\"2026-06-17T21:00:30+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/cryoport-systems-a-labiotech-sur-les-points-de-rupture-des-chaines-dapprovisionnement-de-la-cgt-2\\\/\"},\"wordCount\":22,\"publisher\":{\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/cryoport-systems-a-labiotech-sur-les-points-de-rupture-des-chaines-dapprovisionnement-de-la-cgt-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.cryoport.com\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/ISCT-News-Article.png\",\"keywords\":[\"Gestion de la cha\u00eene d'approvisionnement mondiale\",\"Th\u00e9rapie cellulaire\",\"Th\u00e9rapie g\u00e9nique\"],\"articleSection\":[\"Articles\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/cryoport-systems-a-labiotech-sur-les-points-de-rupture-des-chaines-dapprovisionnement-de-la-cgt-2\\\/\",\"url\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/cryoport-systems-a-labiotech-sur-les-points-de-rupture-des-chaines-dapprovisionnement-de-la-cgt-2\\\/\",\"name\":\"Une nouvelle r\u00e9flexion de l'ISCT examine pourquoi la croissance des CGT n\u00e9cessite un mod\u00e8le op\u00e9rationnel diff\u00e9rent - Cryoport Systems\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/cryoport-systems-a-labiotech-sur-les-points-de-rupture-des-chaines-dapprovisionnement-de-la-cgt-2\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/cryoport-systems-a-labiotech-sur-les-points-de-rupture-des-chaines-dapprovisionnement-de-la-cgt-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.cryoport.com\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/ISCT-News-Article.png\",\"datePublished\":\"2026-06-17T20:53:44+00:00\",\"dateModified\":\"2026-06-17T21:00:30+00:00\",\"description\":\"La mani\u00e8re dont le secteur appr\u00e9hende la question de l\u2019\u00e9chelle commence \u00e0 \u00e9voluer. Depuis des d\u00e9cennies, la croissance du d\u00e9veloppement biopharmaceutique suit un sch\u00e9ma bien connu. \u00c0 mesure que les programmes avancent, la production s\u2019intensifie et le d\u00e9bit augmente, ce qui permet aux traitements de passer d\u2019un cadre d\u2019essais cliniques limit\u00e9s en phase pr\u00e9coce \u00e0 des populations de patients plus larges. Un nouvel article de Cryoport Systems, publi\u00e9 par l\u2019Interna\u0446\u0438\u043e\u043d\u0430l Society for Cell & Gene Therapy (ISCT), examine comment la notion d\u2019\u00e9chelle se comporte diff\u00e9remment dans le domaine des th\u00e9rapies avanc\u00e9es et pourquoi le secteur pourrait devoir repenser les mod\u00e8les op\u00e9rationnels utilis\u00e9s pour les soutenir.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/cryoport-systems-a-labiotech-sur-les-points-de-rupture-des-chaines-dapprovisionnement-de-la-cgt-2\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/cryoport-systems-a-labiotech-sur-les-points-de-rupture-des-chaines-dapprovisionnement-de-la-cgt-2\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/cryoport-systems-a-labiotech-sur-les-points-de-rupture-des-chaines-dapprovisionnement-de-la-cgt-2\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.cryoport.com\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/ISCT-News-Article.png\",\"contentUrl\":\"https:\\\/\\\/www.cryoport.com\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/ISCT-News-Article.png\",\"width\":1200,\"height\":628},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/cryoport-systems-a-labiotech-sur-les-points-de-rupture-des-chaines-dapprovisionnement-de-la-cgt-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/homepage\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Une nouvelle r\u00e9flexion de l’ISCT examine pourquoi la croissance des CGT n\u00e9cessite un mod\u00e8le op\u00e9rationnel diff\u00e9rent\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/\",\"name\":\"Cryoport Systems\",\"description\":\"Enabling the Future of Medicine\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/#organization\",\"name\":\"Cryoport Systems\",\"url\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.cryoport.com\\\/wp-content\\\/uploads\\\/2023\\\/12\\\/systems-square.png\",\"contentUrl\":\"https:\\\/\\\/www.cryoport.com\\\/wp-content\\\/uploads\\\/2023\\\/12\\\/systems-square.png\",\"width\":1200,\"height\":1200,\"caption\":\"Cryoport Systems\"},\"image\":{\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/cryoport\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/856887\",\"https:\\\/\\\/www.youtube.com\\\/user\\\/CryoportVideo\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/#\\\/schema\\\/person\\\/41e3344a83f354e30051a36b4e0a5f86\",\"name\":\"smendez\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3ce9d56659c228959822d42e6e9146f3170fc590e93aa3adda9bb496df111835?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3ce9d56659c228959822d42e6e9146f3170fc590e93aa3adda9bb496df111835?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3ce9d56659c228959822d42e6e9146f3170fc590e93aa3adda9bb496df111835?s=96&d=mm&r=g\",\"caption\":\"smendez\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Une nouvelle r\u00e9flexion de l'ISCT examine pourquoi la croissance des CGT n\u00e9cessite un mod\u00e8le op\u00e9rationnel diff\u00e9rent - Cryoport Systems","description":"La mani\u00e8re dont le secteur appr\u00e9hende la question de l\u2019\u00e9chelle commence \u00e0 \u00e9voluer. Depuis des d\u00e9cennies, la croissance du d\u00e9veloppement biopharmaceutique suit un sch\u00e9ma bien connu. \u00c0 mesure que les programmes avancent, la production s\u2019intensifie et le d\u00e9bit augmente, ce qui permet aux traitements de passer d\u2019un cadre d\u2019essais cliniques limit\u00e9s en phase pr\u00e9coce \u00e0 des populations de patients plus larges. Un nouvel article de Cryoport Systems, publi\u00e9 par l\u2019Interna\u0446\u0438\u043e\u043d\u0430l Society for Cell & Gene Therapy (ISCT), examine comment la notion d\u2019\u00e9chelle se comporte diff\u00e9remment dans le domaine des th\u00e9rapies avanc\u00e9es et pourquoi le secteur pourrait devoir repenser les mod\u00e8les op\u00e9rationnels utilis\u00e9s pour les soutenir.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cryoport.com\/fr\/cryoport-systems-a-labiotech-sur-les-points-de-rupture-des-chaines-dapprovisionnement-de-la-cgt-2\/","og_locale":"fr_FR","og_type":"article","og_title":"Une nouvelle r\u00e9flexion de l'ISCT examine pourquoi la croissance des CGT n\u00e9cessite un mod\u00e8le op\u00e9rationnel diff\u00e9rent - Cryoport Systems","og_description":"La mani\u00e8re dont le secteur appr\u00e9hende la question de l\u2019\u00e9chelle commence \u00e0 \u00e9voluer. Depuis des d\u00e9cennies, la croissance du d\u00e9veloppement biopharmaceutique suit un sch\u00e9ma bien connu. \u00c0 mesure que les programmes avancent, la production s\u2019intensifie et le d\u00e9bit augmente, ce qui permet aux traitements de passer d\u2019un cadre d\u2019essais cliniques limit\u00e9s en phase pr\u00e9coce \u00e0 des populations de patients plus larges. Un nouvel article de Cryoport Systems, publi\u00e9 par l\u2019Interna\u0446\u0438\u043e\u043d\u0430l Society for Cell & Gene Therapy (ISCT), examine comment la notion d\u2019\u00e9chelle se comporte diff\u00e9remment dans le domaine des th\u00e9rapies avanc\u00e9es et pourquoi le secteur pourrait devoir repenser les mod\u00e8les op\u00e9rationnels utilis\u00e9s pour les soutenir.","og_url":"https:\/\/www.cryoport.com\/fr\/cryoport-systems-a-labiotech-sur-les-points-de-rupture-des-chaines-dapprovisionnement-de-la-cgt-2\/","og_site_name":"Cryoport Systems","article_published_time":"2026-06-17T20:53:44+00:00","article_modified_time":"2026-06-17T21:00:30+00:00","og_image":[{"width":1200,"height":628,"url":"https:\/\/www.cryoport.com\/wp-content\/uploads\/2026\/06\/ISCT-News-Article.png","type":"image\/png"}],"author":"smendez","twitter_card":"summary_large_image","twitter_creator":"@cryoport","twitter_site":"@cryoport","twitter_misc":{"\u00c9crit par":"smendez"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.cryoport.com\/fr\/cryoport-systems-a-labiotech-sur-les-points-de-rupture-des-chaines-dapprovisionnement-de-la-cgt-2\/#article","isPartOf":{"@id":"https:\/\/www.cryoport.com\/fr\/cryoport-systems-a-labiotech-sur-les-points-de-rupture-des-chaines-dapprovisionnement-de-la-cgt-2\/"},"author":{"name":"smendez","@id":"https:\/\/www.cryoport.com\/fr\/#\/schema\/person\/41e3344a83f354e30051a36b4e0a5f86"},"headline":"Une nouvelle r\u00e9flexion de l’ISCT examine pourquoi la croissance des CGT n\u00e9cessite un mod\u00e8le op\u00e9rationnel diff\u00e9rent","datePublished":"2026-06-17T20:53:44+00:00","dateModified":"2026-06-17T21:00:30+00:00","mainEntityOfPage":{"@id":"https:\/\/www.cryoport.com\/fr\/cryoport-systems-a-labiotech-sur-les-points-de-rupture-des-chaines-dapprovisionnement-de-la-cgt-2\/"},"wordCount":22,"publisher":{"@id":"https:\/\/www.cryoport.com\/fr\/#organization"},"image":{"@id":"https:\/\/www.cryoport.com\/fr\/cryoport-systems-a-labiotech-sur-les-points-de-rupture-des-chaines-dapprovisionnement-de-la-cgt-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cryoport.com\/wp-content\/uploads\/2026\/06\/ISCT-News-Article.png","keywords":["Gestion de la cha\u00eene d'approvisionnement mondiale","Th\u00e9rapie cellulaire","Th\u00e9rapie g\u00e9nique"],"articleSection":["Articles"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/www.cryoport.com\/fr\/cryoport-systems-a-labiotech-sur-les-points-de-rupture-des-chaines-dapprovisionnement-de-la-cgt-2\/","url":"https:\/\/www.cryoport.com\/fr\/cryoport-systems-a-labiotech-sur-les-points-de-rupture-des-chaines-dapprovisionnement-de-la-cgt-2\/","name":"Une nouvelle r\u00e9flexion de l'ISCT examine pourquoi la croissance des CGT n\u00e9cessite un mod\u00e8le op\u00e9rationnel diff\u00e9rent - Cryoport Systems","isPartOf":{"@id":"https:\/\/www.cryoport.com\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cryoport.com\/fr\/cryoport-systems-a-labiotech-sur-les-points-de-rupture-des-chaines-dapprovisionnement-de-la-cgt-2\/#primaryimage"},"image":{"@id":"https:\/\/www.cryoport.com\/fr\/cryoport-systems-a-labiotech-sur-les-points-de-rupture-des-chaines-dapprovisionnement-de-la-cgt-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cryoport.com\/wp-content\/uploads\/2026\/06\/ISCT-News-Article.png","datePublished":"2026-06-17T20:53:44+00:00","dateModified":"2026-06-17T21:00:30+00:00","description":"La mani\u00e8re dont le secteur appr\u00e9hende la question de l\u2019\u00e9chelle commence \u00e0 \u00e9voluer. Depuis des d\u00e9cennies, la croissance du d\u00e9veloppement biopharmaceutique suit un sch\u00e9ma bien connu. \u00c0 mesure que les programmes avancent, la production s\u2019intensifie et le d\u00e9bit augmente, ce qui permet aux traitements de passer d\u2019un cadre d\u2019essais cliniques limit\u00e9s en phase pr\u00e9coce \u00e0 des populations de patients plus larges. Un nouvel article de Cryoport Systems, publi\u00e9 par l\u2019Interna\u0446\u0438\u043e\u043d\u0430l Society for Cell & Gene Therapy (ISCT), examine comment la notion d\u2019\u00e9chelle se comporte diff\u00e9remment dans le domaine des th\u00e9rapies avanc\u00e9es et pourquoi le secteur pourrait devoir repenser les mod\u00e8les op\u00e9rationnels utilis\u00e9s pour les soutenir.","breadcrumb":{"@id":"https:\/\/www.cryoport.com\/fr\/cryoport-systems-a-labiotech-sur-les-points-de-rupture-des-chaines-dapprovisionnement-de-la-cgt-2\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cryoport.com\/fr\/cryoport-systems-a-labiotech-sur-les-points-de-rupture-des-chaines-dapprovisionnement-de-la-cgt-2\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.cryoport.com\/fr\/cryoport-systems-a-labiotech-sur-les-points-de-rupture-des-chaines-dapprovisionnement-de-la-cgt-2\/#primaryimage","url":"https:\/\/www.cryoport.com\/wp-content\/uploads\/2026\/06\/ISCT-News-Article.png","contentUrl":"https:\/\/www.cryoport.com\/wp-content\/uploads\/2026\/06\/ISCT-News-Article.png","width":1200,"height":628},{"@type":"BreadcrumbList","@id":"https:\/\/www.cryoport.com\/fr\/cryoport-systems-a-labiotech-sur-les-points-de-rupture-des-chaines-dapprovisionnement-de-la-cgt-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.cryoport.com\/fr\/homepage\/"},{"@type":"ListItem","position":2,"name":"Une nouvelle r\u00e9flexion de l’ISCT examine pourquoi la croissance des CGT n\u00e9cessite un mod\u00e8le op\u00e9rationnel diff\u00e9rent"}]},{"@type":"WebSite","@id":"https:\/\/www.cryoport.com\/fr\/#website","url":"https:\/\/www.cryoport.com\/fr\/","name":"Cryoport Systems","description":"Enabling the Future of Medicine","publisher":{"@id":"https:\/\/www.cryoport.com\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cryoport.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.cryoport.com\/fr\/#organization","name":"Cryoport Systems","url":"https:\/\/www.cryoport.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.cryoport.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.cryoport.com\/wp-content\/uploads\/2023\/12\/systems-square.png","contentUrl":"https:\/\/www.cryoport.com\/wp-content\/uploads\/2023\/12\/systems-square.png","width":1200,"height":1200,"caption":"Cryoport Systems"},"image":{"@id":"https:\/\/www.cryoport.com\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/cryoport","https:\/\/www.linkedin.com\/company\/856887","https:\/\/www.youtube.com\/user\/CryoportVideo"]},{"@type":"Person","@id":"https:\/\/www.cryoport.com\/fr\/#\/schema\/person\/41e3344a83f354e30051a36b4e0a5f86","name":"smendez","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/3ce9d56659c228959822d42e6e9146f3170fc590e93aa3adda9bb496df111835?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/3ce9d56659c228959822d42e6e9146f3170fc590e93aa3adda9bb496df111835?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/3ce9d56659c228959822d42e6e9146f3170fc590e93aa3adda9bb496df111835?s=96&d=mm&r=g","caption":"smendez"}}]}},"_links":{"self":[{"href":"https:\/\/www.cryoport.com\/fr\/wp-json\/wp\/v2\/posts\/27875","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cryoport.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cryoport.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cryoport.com\/fr\/wp-json\/wp\/v2\/users\/38"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cryoport.com\/fr\/wp-json\/wp\/v2\/comments?post=27875"}],"version-history":[{"count":2,"href":"https:\/\/www.cryoport.com\/fr\/wp-json\/wp\/v2\/posts\/27875\/revisions"}],"predecessor-version":[{"id":27895,"href":"https:\/\/www.cryoport.com\/fr\/wp-json\/wp\/v2\/posts\/27875\/revisions\/27895"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cryoport.com\/fr\/wp-json\/wp\/v2\/media\/27881"}],"wp:attachment":[{"href":"https:\/\/www.cryoport.com\/fr\/wp-json\/wp\/v2\/media?parent=27875"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cryoport.com\/fr\/wp-json\/wp\/v2\/categories?post=27875"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cryoport.com\/fr\/wp-json\/wp\/v2\/tags?post=27875"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}